BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15255830)

  • 1. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
    Jagadheesan K; Muirhead D
    Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830
    [No Abstract]   [Full Text] [Related]  

  • 2. Tardive dyskinesia in a patient treated with quetiapine.
    Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
    World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.
    Chen YY; Huang MC; Wu KC
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):620-1. PubMed ID: 18950385
    [No Abstract]   [Full Text] [Related]  

  • 4. Amisulpride-induced mania with interictal psychosis.
    Bakhla AK; Goyal N; Nizamie SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1572-3. PubMed ID: 19766159
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

  • 6. Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report.
    Yalcin DO; Goka E; Aydemir MC; Kisa C
    J Psychopharmacol; 2008 May; 22(3):333-5. PubMed ID: 18208928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 8. Quetiapine combined with amisulpride in schizophrenic patients with insufficient responses to quetiapine monotherapy.
    Englisch S; Enning F; Grosshans M; Marquardt L; Waltereit R; Zink M
    Clin Neuropharmacol; 2010; 33(5):227-9. PubMed ID: 20838213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amisulpride--an open clinical study of a new benzamide in schizophrenic patients.
    Mann K; Bartels M; Bauer H; Gaertner HJ
    Pharmacopsychiatry; 1984 Jul; 17(4):111-5. PubMed ID: 6147865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulpiride-induced tardive dystonia.
    Miller LG; Jankovic J
    Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of quetiapine in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2002; 63 Suppl 13():27-31. PubMed ID: 12562144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands].
    Vinkers CH; Sommer IE
    Tijdschr Psychiatr; 2015; 57(11):830-4. PubMed ID: 26552930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General practice study with atypical neuroleptics. Differences in tolerance].
    MMW Fortschr Med; 2002 May; Suppl 2():86. PubMed ID: 12070866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
    Barrimi M; El Ghazouani F; Zaimi O; Oneib B
    Presse Med; 2018 Feb; 47(2):172-174. PubMed ID: 29395559
    [No Abstract]   [Full Text] [Related]  

  • 16. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms.
    Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T
    Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Müller MJ; Eich FX; Regenbogen B; Sachse J; Härtter S; Hiemke C
    J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride and symptomatic bradycardia: a case report.
    Huang LC; Huang LY; Tseng SY; Hou YM; Hsiao CC
    Gen Hosp Psychiatry; 2015; 37(5):497.e1-2. PubMed ID: 26162544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.
    Lang UE; Willbring M; von Golitschek R; Schmeisser A; Matschke K; Malte Tugtekin S
    J Psychopharmacol; 2008 Jul; 22(5):576-80. PubMed ID: 18308817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.